Neurotherapy for Concussions in Colorado Springs

During a biofeedback session, sensors are placed on the scalp to monitor brainwave patterns, which are then displayed on a screen. Patients learn to regulate their brainwaves through guided exercises and mental strategies, aiming to achieve a desired state of relaxation, focus, or alertness. By mastering these techniques, patients can improve their cognitive functions, manage stress more effectively, and enhance their overall emotional well-being. This self-regulation skill is particularly beneficial for those recovering from a concussion, as it helps restore balance to brain functions disrupted by the injury.

This assessment involves placing electrodes on the scalp to record brainwave patterns, which are then analyzed using advanced software to identify any abnormalities or areas of dysfunction. The detailed brain maps produced by QEEG allow our specialists to pinpoint specific regions that may be underactive or overactive. With this precise information, we can tailor neurotherapy treatments to address the unique needs of each patient, ensuring a targeted and effective approach to concussion recovery. QEEG is invaluable for creating personalized treatment plans that promote optimal brain health and function.

The Alpha Stim device delivers low-level electrical currents through electrodes placed on the earlobes, which stimulate the brain’s natural electrical activity. This non-invasive and painless method has been shown to promote relaxation, improve mood, and enhance sleep quality. By modulating brainwaves, Alpha Stim helps restore balance and supports the brain’s healing processes. This therapy is particularly effective for concussion patients, as it addresses both the cognitive and emotional challenges that often accompany brain injuries, facilitating a more comprehensive and holistic recovery.

The technology of Vielight dates back to 1995 in the Silicon Valley – when the founders, Dr. Lew Lim and a group of engineers explored the potential of intranasal photobiomodulation. Intranasal photobiomodulation devices were commercially developed in 2003, which were later trademarked as “Vielight” when the company was incorporated in 2011.

Over the years, the focus shifted towards the development of unique photobiomodulation devices which enhance cognition and performance, among other things.